• AkzoNobel’s pending all-share merger of equals with Axalta was revised to strengthen governance following shareholder discussions.
• All directors will face annual re-election starting three years after closing, shortened from five years.
• During the first three years, key board and executive decisions will require support from two-thirds of non-executive directors, lowered from 75%.
• AkzoNobel and Axalta shareholder meetings remain scheduled for Aug. 5, 2026, with agenda items unchanged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akzo Nobel NV published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein.